LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway.
Saved in:
| Title: | LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway. |
|---|---|
| Authors: | Zhou SZ; Department of Pulmonary Disease, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine , Zhengzhou, P. R China., Li H; Department of Pulmonary Disease, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine , Zhengzhou, P. R China., Wang ZW; Department of Pulmonary Disease, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine , Zhengzhou, P. R China., Wang MH; Department of Pulmonary Disease, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine , Zhengzhou, P. R China., Li N; Department of Pulmonary Disease, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine , Zhengzhou, P. R China., Wang YF; Department of Pulmonary Disease, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine , Zhengzhou, P. R China. |
| Source: | Cell cycle (Georgetown, Tex.) [Cell Cycle] 2020 Nov; Vol. 19 (21), pp. 2776-2792. Date of Electronic Publication: 2020 Oct 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1551-4005 (Electronic) Linking ISSN: 15514005 NLM ISO Abbreviation: Cell Cycle Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1551-4005 |
|---|---|
| DOI: | 10.1080/15384101.2020.1820697 |
